News of Center PharmaCOVID |
|
Yu.Yu. Kiselev (1), K.B. Mirzaev (2)
Possibilities of using glucocorticosteroids in the outpatient treatment of patients with COVID-19
|
12-13 |
|
I.S. Burashnikova (1), V.M. Tsvetov (2)
Drug therapy for asymptomatic carriers of SARS-CoV-2
|
14-16 |
|
K.B. Mirzaev (1), V.M. Tsvetov (2)
Scientific rationale for the use of remdesivir in patients with COVID-19
|
17-20 |
REVIEWS |
|
E.A. Aseeva (1), S.K. Soloviev (2), N.Yu. Nikishina (2), E.L. Nasonov (1), A.M. Lila (1)
Standard and innovative treatments for systemic lupus erythematosus
|
21-28 |
|
O.D. Ostroumova (1, 2), A.I. Kochetkov (1)
The role of the disturbances in the intestinal barrier structure in relation to cardiovascular diseases pathogenesis and rebamipid potential in their correction
|
30-41 |
|
A.M. Tkachev (1, 3), A.V. Epifanov (4), E.S. Akarachkova (2), I.E. Gordeeva (3)
Herniated disc resorption: a review of studies
|
42-48 |
|
O.D. Ostroumova (1), A.P. Pereverzev (1), E.E. Pavleeva (2), A.G. Komarova (3)
Drug-induced liver injury with cholestasis. Part 1: focus on drugs for the treatment of cardiovascular diseases and hypoglycemic drugs
|
49-57 |
|
M.N. Chikina, M.S. Eliseev
Controversial issues of gout treatment
|
58-64 |
|
|
N.M. Vorobyeva, O.N. Tkacheva
Safety issues of antiplatelet and anticoagulant therapy in cardiological practice
|
65-74 |
ORIGINAL ARTICLES |
|
A.S. Misiyuk (1), A.M. Lila (1, 2), E.A. Galushko (1), G.V. Lukina (1, 3), A.V. Kudryavtseva (1)
Comparative efficacy of janus kinase therapy and anti-β-cell therapy for patients with rheumatoid arthritis resistant to standard disease modifying anti-rheumatic drugs, based on the results of real clinical practice
|
75-80 |
|
E.Yu. Mozheyko, E.M. Zubritskaya, E.G. Shanina, V.S. Ondar, S.A. Subocheva
Antioxidant therapy in the treatment of patients with chronic cerebral ischemia
|
81-86 |
|
E.P. Sharapova, L.I. Alekseeva, E.A. Taskina, N.G. Kashevarova, S.G. Anikin, T.A. Korotkova, E.A. Strebkova, А.M. Lila
Efficacy and safety of Alflutop in the treatment of patients with osteoarthritis of the knee joints: multicenter open-label randomized clinical trial
|
87-95 |
|
S.S. Kochkartaev (1), E.A. Danilova (2), Sh.Sh. Shatursunov (1), N.S. Osinskaya (2)
Microelement composition of intervertebral discs in lumbar osteochondrosis
|
96-100 |
|
E.S. Filatova (1), L.I. Alekseeva (1), E.A. Taskina (1), N.G. Kashevarova (1), E.P. Sharapova (1), A.M. Lila (1, 2)
Efficacy and safety of combination therapy with aceclofenac and pregabalin, compared with aceclofenac monotherapy for chronic pain in patients with osteoarthritis of the knee joints
|
101-107 |
|
A.A. Rakhmanova, A.P. Skorokhodov, V.A. Kutashov
Evaluation of the effectiveness of the method of treatment of cognitive disorders with the integrated use of transcranial magnetic stimulation in ischemic stroke patients in the late recovery period
|
108-113 |
|
V.G. Tregubov (1), P.V. Khilkevich (1), I.Z. Shubitidze (2), M.V. Tregubova (1)
Evaluation of the effect of bisoprolol and carvedilol on the functional status of patients with chronic heart failure and preserved left ventricular ejection fraction
|
114-118 |
|
|
A.A. Pilipovich, A.B. Danilov
Back pain: selection of therapy in terms of effectiveness and safety
|
119-125 |
|
A.V. Torgashina
A modern view of the treatment of Sjogren’s disease
|
126-131 |
|
S.E. Khatkova (1), E.A. Nikolaev (1), V.P. Diagileva (1), O.G. Pavlova (2), V.Ju. Roshhin (3), M.A. Akulov (4), V.O. Zakharov (4)
Unresolved issues of rehabilitation of patients with spastic hemiparesis and sensitive disorders after stroke. Description of a clinical case
|
132-141 |
|
D.G. Rumiantceva, M.V. Podryadnova, O.A. Rumyantseva, M.M. Urumova, Sh.F. Erdes
A series of clinical cases of severe course of ankylosing spondylitis with ineffectiveness to standard therapy
|
142-146 |
|
M.I. Ivanova (1), P.P. Ikonnikov (2), D.S. Maznev (2), A.A. Kozak (1), P.V. Lisukova (1)
A clinical case of thrombotic complications in a patient with hereditary thrombophilia and pulmonary arteriovenous malformation
|
147-151 |
Русский
